AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machado, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machado, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 3220-3221, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00473-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-Producing Enterobacteriaceae Strains Containing the aac(6')-Ib-cr Gene, Which Encodes an Aminoglycoside- and Fluoroquinolone-Modifying Enzyme


    LETTER
 Top
 Letter
 References
 
CTX-M-15, recently detected in Portugal, is an extended-spectrum ß-lactamase (ESBL) that has spread worldwide (3, 4, 9, 10, 15). The basis for the successful dissemination of blaCTX-M-15 is unknown, although the spread of epidemic Escherichia coli strains and/or conjugative plasmids harboring blaCTX-M-15 has been documented (3, 6).

We report the dissemination of blaCTX-M-15 associated with strains and plasmids harboring blaOXA-1, blaTEM-1, and the recently described aac(6')-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme (12) in different Portuguese regions.

During a surveillance study of ESBL-producing isolates in two hospitals and one ambulatory laboratory in three different Portuguese cities (January 2003 to October 2004), we identified 17 E. coli and 2 Klebsiella pneumoniae isolates producing CTX-M-15 (Table 1). Susceptibility testing and characterization of ß-lactamases were performed by standard methods (2, 7). The presence of resistance genes such as aac(6')-Ib-cr, qnrA, or qnrB or sequences linked to CTX-M-genetic environments such as ISEcp1, IS903, class 1 integrons, or CR1 (also named open reading frame 513 [ORF513]) was investigated by PCR and sequencing (5, 7, 8, 12, 13). PCR experiments based on published sequences (GenBank accession no. AY458016 and AY259086) were performed to search the vicinity of particular genes. Clonal relatedness was established by pulsed-field gel electrophoresis (PFGE) and identification of E. coli phylogenetic groups by a multiplex PCR assay (7). Conjugation experiments were carried out as described previously (7). Plasmid analysis included estimation of plasmid number and size and comparison of EcoRI-digested DNA patterns (1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Characterization of CTX-M-15-producing isolates

 
All isolates were nonsusceptible to amoxicillin-clavulanic acid, cefotaxime, ceftazidime, aztreonam, cefepime, nalidixic acid, ciprofloxacin, and, with the exception of one K. pneumoniae isolate, kanamycin, gentamicin, and tobramycin. E. coli isolates were grouped into three PFGE types belonging to phylogenetic group B2. Isolates of PFGE type A were predominant, being recovered from different wards in hospitals in the north and center regions and from an outpatient living geographically apart from both institutions. The K. pneumoniae isolates showed identical PFGE patterns.

Most strains simultaneously produced CTX-M-15, OXA-1, and TEM-1. The gene blaCTX-M-15 was located 49 nucleotides downstream of ISEcp1 in plasmids of 85 (n = 16), 100 (n = 1), or 120 (n = 2) kb. The presence of IS903 was detected only in K. pneumoniae isolates. When transferred by conjugation (achieved in one K. pneumoniae isolate and four E. coli isolates), blaCTX-M-15 was accompanied by blaOXA-1, blaTEM-1, and genes coding for decreased susceptibility to tetracycline, kanamycin, gentamicin, tobramycin, amikacin, and ciprofloxacin.

We identified the gene cassette array aac(6')-Ib-cr-blaOXA-1 in all CTX-M-15- and OXA-1-producing isolates, despite the absence of detectable class 1 integrons, CR1, qnrA, or qnrB, as also happens in pC15-1a, the epidemic plasmid coding for CTX-M-15 described in Canada (3). It is of note that the recently described aac(6')-Ib-cr gene, which reduces the activity of both aminoglycosides (kanamycin, tobramycin, and amikacin) and fluoroquinolones (ciprofloxacin and norfloxacin), appears to be associated with blaOXA-1 either in In37, a class 1 integron bearing CR1 and carrying qnrA, or in the multiresistance region of pC15-1a, even though this has not been recognized to date (3, 12, 13).

Our results indicate that current dissemination of blaCTX-M-15 in Portugal is linked to an epidemic E. coli strain of phylogroup B2 and/or plasmids also containing blaOXA-1, blaTEM-1, and aac(6')-Ib-cr resistance genes, both sharing similar features with others reported in different continents (3, 6, 11, 14). These findings are of concern since different selective pressures might contribute to the persistence and broad dissemination of these multiresistant genetic elements. They also suggest that the relationships among epidemic genetic elements bearing blaCTX-M-15 of distinct geographical areas require further investigation.


    ACKNOWLEDGMENTS
 
Elisabete Machado was supported by a fellowship from Fundação para a Ciência e a Tecnologia de Portugal (SFRH/BD/11304/2002).

Contributing members of the Portuguese Resistance Study Group are Helena Ramos, Hospital Geral de Santo António (NH), Porto, Portugal; Graça Ribeiro and Clementina Vital, Hospitais Universitários de Coimbra (CH), Coimbra, Portugal; and Sónia Magalhães, LabFafe (NAL), Fafe, Portugal.


    REFERENCES
 Top
 Letter
 References
 

  1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.[CrossRef][Medline]
  2. Bert, F., C. Branger, and N. Lambert-Zechovsky. 2002. Identification of PSE and OXA ß-lactamases in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.[Abstract/Free Full Text]
  3. Boyd, D. A., S. Tyler, S. Christianson, A. McGeer, M. P. Muller, B. M. Willey, E. Bryce, M. Gardam, P. Nordmann, M. R. Mulvey, and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48:3758-3764.[Abstract/Free Full Text]
  4. Conceição, T., A. Brizio, A. Duarte, L. M. Lito, J. M. Cristino, and M. J. Salgado. 2005. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob. Agents Chemother. 49:477-478. (Letter.)[Free Full Text]
  5. Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.[Abstract/Free Full Text]
  6. Leflon-Guibout, V., C. Jurand, S. Bonacorsi, F. Espinasse, M. C. Guelfi, F. Duportail, B. Heym, E. Bingen, and M. H. Nicolas-Chanoine. 2004. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 48:3736-3742.[Abstract/Free Full Text]
  7. Machado, E., R. Cantón, F. Baquero, J. C. Galán, A. Rollán, L. Peixe, and T. M. Coque. 2005. Integron content of extended-spectrum-ß-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob. Agents Chemother. 49:1823-1829.[Abstract/Free Full Text]
  8. Machado, E., T. M. Coque, R. Cantón, J. C. Sousa, and L. Peixe. 2004. Emergence of CTX-M beta-lactamase-producing Enterobacteriaceae in Portugal: report of an Escherichia coli isolate harbouring blaCTX-M-14. Clin. Microbiol. Infect. 10:755-757.[CrossRef][Medline]
  9. Mendonça, N., D. Louro, A. P. Castro, J. Diogo, and M. Caniça. 2006. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions. J. Antimicrob. Chemother. 57:1014-1016.[Free Full Text]
  10. Moubarek, C., Z. Daoud, N. I. Hakimé, M. Hamzé, N. Mangeney, H. Matta, J. E. Mokhbat, R. Rohban, D. K. Sarkis, and F. Doucet-Populaire. 2005. Countrywide spread of community- and hospital-acquired extended-spectrum ß-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J. Clin. Microbiol. 43:3309-3313.[Abstract/Free Full Text]
  11. Pai, H., M. R. Kim, M. R. Seo, T. Y. Choi, and S. H. Oh. 2006. A nosocomial outbreak of Escherichia coli producing CTX-M-15 and OXA-30 beta-lactamase. Infect. Control Hosp. Epidemiol. 27:312-314.[CrossRef][Medline]
  12. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.[CrossRef][Medline]
  13. Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]
  14. Weill, F. X., J. D. Perrier-Gros-Claude, M. Demarrin, S. Coignard, and P. A. Grimont. 2004. Characterization of extended-spectrum ß-lactamase (CTX-M-15)-producing strains of Salmonella enterica isolated in France and Senegal. FEMS Microbiol. Lett. 238:353-358.[Medline]
  15. Woodford, N., M. E. Ward, M. E. Kaufmann, J. Turton, E. J. Fagan, D. James, A. P. Johnson, R. Pike, M. Warner, T. Cheasty, A. Pearson, S. Harry, J. B. Leach, A. Loughrey, J. A. Lowes, R. E. Warren, and D. M. Livermore. 2004. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum ß-lactamases in UK. J. Antimicrob. Chemother. 54:735-743.[Abstract/Free Full Text]
Elisabete Machado
REQUIMTE
Laboratório de Microbiologia
Faculdade de Farmácia da Universidade do Porto
Porto, Portugal,1

Teresa M. Coque
Rafael Cantón
Fernando Baquero

Servicio de Microbiología
Hospital Universitario Ramón y Cajal
Madrid, Spain,2

João Carlos Sousa
Faculdade de Ciências da Saúde
Universidade Fernando Pessoa
Porto, Portugal,3

Luísa Peixe*
The Portuguese Resistance Study Group

Laboratório de Microbiologia
Faculdade de Farmácia
Universidade do Porto
Rua Aníbal Cunha, 164
4050-047 Porto, Portugal,4

* Phone: 351-22-2078946
Fax: 351-22-2003977
E-mail: lpeixe{at}ff.up.pt.


Antimicrobial Agents and Chemotherapy, September 2006, p. 3220-3221, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00473-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machado, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machado, E.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS